1. Home
  2. Our Firm
  3. News
  4. Seamus Fernandez to Join Guggenheim Securities as Pharmaceuticals Analyst

Our Firm

March 23, 2018

Seamus Fernandez to Join Guggenheim Securities as Pharmaceuticals Analyst

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Seamus Fernandez will join the firm in June as a Senior Analyst and Senior Managing Director in a planned expansion of the firm’s Healthcare Research team. He will focus on companies in the pharmaceuticals industry globally and coordinate the firm’s research coverage of therapeutics.

Mr. Fernandez joins Guggenheim from LEERINK Partners, where he spent more than 10 years and served as a Managing Director covering major pharmaceutical and biotechnology companies, as well as specialty pharmaceuticals. Previous to joining LEERINK in 2006, he was a member of the Pharmaceuticals team at Cowen and Company’s Research Division. Mr. Fernandez began his career as a Research Associate at the University of Pennsylvania’s Department of Neurosurgery.

“We are excited for Seamus to join our Healthcare Research team,” said Stefano Natella, Director of Equity Research. “His deep industry knowledge, his ability to focus on the long-term issues driving this sector, and his differentiated approach to research will be key assets for our expanding research department. We look forward to his continued success at Guggenheim.”

Mr. Fernandez received his B.A. in Chemistry from Williams College.


About Guggenheim Securities

Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, Los Angeles, San Francisco, and Houston. For more information, please contact us at GSinfo@GuggenheimPartners.com or 212.518.9200.

About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $305 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With more than 2,300 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.


Media Contact

Ellen Cunningham
Guggenheim Partners
212.518.9578
Ellen.N.Cunningham@GuggenheimPartners.com

 

1Assets under management are as of 12.31.2017 and include consulting services for clients whose assets are valued at approximately $66bn.



August 20, 2018

Guggenheim 3Q Fixed-Income Outlook: Growing Tail Risks Threaten Economic Growth and Market Performance

Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today provided its Third Quarter 2018 Fixed-Income Outlook, “Tail Risks Are Getting Fatter.”

Read More

July 17, 2018

Whitney Ijem Joins Guggenheim Securities as Biotech Analyst

Guggenheim Securities announced today that Whitney Ijem has joined the firm as a Director in a planned expansion of the Healthcare Research team. Ms. Ijem is focusing on the coverage of Biotech companies, working closely with the firm’s growing therapeutics team.

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.